Q2 2026 · Form 13F Ledger数据来源:SEC EDGAR  
H

HOLDER.TOP

谁持有什么——美股机构持仓的季度账本。
EN · 简 · 繁
机构 / Frazier Life Sciences Management, L.P.
Form 13F · Q2 2026

Frazier Life Sciences Management, L.P.

CIK 1892134申报日 2026-08-1413F-HR 在 EDGAR 查看原始申报 ↗
$45.9亿
申报组合市值
41
持仓数量
12
Quarters on record
Top 50
持仓数量

Frazier Life Sciences Management, L.P.——持仓

共 41 个持仓中的前 41 名,按申报市值排名。股数变动与上一季度对比。
#证券股数股数环比市值占其组合
1MIRM Mirum Pharmaceuticals Inc7.7M+0.0%$9.0亿19.6%
2NAMS Newamsterdam Pharma Company18.1M+6.8%$6.1亿13.3%
3ERAS Erasca Inc25.0M+1.2%$4.6亿10.0%
4MBX Mbx Biosciences Inc6.7M+0.0%$3.7亿8.0%
5ARQT Arcutis Biotherapeutics Inc9.9M+0.0%$2.6亿5.6%
6TRVI Trevi Therapeutics Inc9.9M−0.0%$1.9亿4.0%
7KRYS Krystal Biotech Inc481,307+0.0%$1.8亿3.9%
8MAZE Maze Therapeutics Inc5.0M+10.2%$1.5亿3.3%
9PHAT Phathom Pharmaceuticals Inc12.5M+0.0%$1.4亿2.9%
10PVLA Palvella Therapeutics Inc Ne882,400+0.0%$1.3亿2.9%
11BBIO Bridgebio Pharma Inc1.5M−55.1%$1.2亿2.5%
12IRON Disc Medicine Inc1.4M+0.0%$9909万2.2%
13CYTK Cytokinetics Inc1.2M+0.0%$9881万2.2%
14DYN Dyne Therapeutics Inc3.2M+0.0%$7003万1.5%
15ASND Ascendis Pharma A/S225,155+68.9%$6005万1.3%
16SVRA Savara Inc9.7M+0.0%$5988万1.3%
17PBLS Parabilis Medicines Inc1.9M—$5257万1.1%
18AURA Aura Biosciences Inc7.1M+39.2%$5041万1.1%
19QUIT Achieve Life Science Inc7.6M—$4972万1.1%
20VOR Vor Biopharma Inc2.5M+0.0%$4683万1.0%
21ALLO Allogene Therapeutics Inc22.4M+491.2%$4669万1.0%
22TARS Tarsus Pharmaceuticals Inc728,644+0.0%$4586万1.0%
23BCRX Biocryst Pharmaceuticals Inc4.0M+0.0%$4009万0.9%
24ALKS Alkermes Plc700,647+0.0%$3671万0.8%
25ACAD Acadia Pharmaceuticals Inc1.4M+0.0%$3639万0.8%
26ZLAB Zai Lab Ltd1.9M+0.0%$3614万0.8%
27MNKD Mannkind Corp6.6M+11.9%$2812万0.6%
28DSGN Design Therapeutics Inc1.8M—$2619万0.6%
29ACRS Aclaris Therapeutics Inc4.9M+0.0%$2606万0.6%
30STTK Shattuck Labs Inc3.8M—$2602万0.6%
31KLRA Kailera Therapeutics Inc1.1M—$2423万0.5%
32GLUE Monte Rosa Therapeutics Inc1.0M+0.0%$2420万0.5%
33LXEO Lexeo Therapeutics Inc4.8M+9.0%$2246万0.5%
34RLAY Relay Therapeutics Inc1.0M—$1900万0.4%
35EOLS Evolus Inc2.6M+0.0%$1826万0.4%
36IMCR Immunocore Hldgs Plc484,782+0.0%$1539万0.3%
37VALN Valneva Se2.3M+0.0%$1199万0.3%
38NAMS Newamsterdam Pharma Company500,333+0.0%$1069万0.2%
39AUTL Autolus Therapeutics Ltd4.4M+0.0%$712万0.2%
40XLO Xilio Therapeutics Inc422,505+0.0%$405万0.1%
41IBIO Ibio Inc2.0M+0.0%$342万0.1%
来源:经 SEC EDGAR 的 Form 13F 申报。持仓截至 2026 年 6 月 30 日。期权(看涨/看跌)不计入股数。